Abbott Laboratories' stock opened lower on Friday, dropping from $129.89 to $125.00 before trading at $126.04. Despite this ...

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...

Bank of America raised Abbott Laboratories’ price target from $133 to $150, maintaining a buy rating on the stock. Other ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a ...

Texas Gov. Greg Abbott awarded $23.25 million to Austin-based Silicon Labs on Wednesday as part of the state's Semiconductor ...

Two former employees say the Scarborough plant failed to accommodate their disabilities and created a hostile work ...

Abbott's rapid tests were fast-tracked through the FDA for emergency use, and in 2020, the company entered into a $750 million contract with the White House to provide 150 million tests.

Medtronic ( MDT -0.99%) and Abbott Laboratories ( ABT -1.91%) are two such examples in the healthcare industry. Both are ...